Cargando…
Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic
OBJECTIVES: Caring for osteoporosis patients has proven challenging during the COVID-19 pandemic due to repeated lockdowns in Austria. The distinct possibility of insufficient treatment regimens is therefore a matter of pressing concern. The aim of the study was to assess alterations in dispensing a...
Autores principales: | Kocijan, Roland, Stockinger, Theresa, Haschka, Judith, Reichardt, Berthold, Resch, Heinrich, Zwerina, Jochen, Behanova, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239920/ https://www.ncbi.nlm.nih.gov/pubmed/35779846 http://dx.doi.org/10.1016/j.bone.2022.116477 |
Ejemplares similares
-
Poor adherence to parenteral osteoporosis therapies during COVID-19 pandemic
por: Kocijan, Roland, et al.
Publicado: (2021) -
Pelvic Fractures—An Underestimated Problem? Incidence and Mortality Risk after Pelvic Fracture in Austria, 2010–2018
por: Behanova, Martina, et al.
Publicado: (2022) -
Identifying adult hypophosphatasia in the rheumatology unit
por: Feurstein, Julia, et al.
Publicado: (2022) -
Fractal-Based Analysis of Bone Microstructure in Crohn’s Disease: A Pilot Study
por: Haschka, Judith, et al.
Publicado: (2020) -
Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis—the MiDeTe study
por: Messner, Zora, et al.
Publicado: (2022)